all about terminal illnesses
← All diseases Rare and hereditary disorders

Mucopolysaccharidosis

Do you want to be notified when there is new research about Mucopolysaccharidosis? This is possible with an account. Create a free account or log in.

Last updated: 2026-08-10 · automatically checked, spot-checked

# Alternative treatment approaches in mucopolysaccharidosis

Mucopolysaccharidosis (MPS) is an inherited metabolic disorder for which standard treatment consists of enzyme replacement therapy, symptom management and prevention of complications. In addition, patients and healthcare providers seek complementary or alternative approaches. Below is an overview of what is known about this.

Enzyme replacement therapy (ERT) with human or synthetic enzymes

ProveniIncluded in official guidelines, or approved by EMA or FDA

Enzyme replacement therapy has been a recognized standard treatment for various MPS types since the early 2000s. The missing enzyme is introduced into the body via infusions. This can slow or stabilize the progression of symptoms, especially when started early. Effectiveness varies by MPS type and individual patient. For MPS I (Hurler), MPS II (Hunter) and MPS VI (Maroteaux-Lamy) approved preparations are available; for other types ERT is less developed or absent. Regular infusions (usually weekly to fortnightly) are necessary and can cause infusion-related reactions.

Management of pain complaints

ResearchediPositive results in clinical studies, not yet standard treatment

Pain is a common problem in MPS patients, caused by joint stiffness, skeletal deformities and nerve compression. As research from 2024 indicates that pain management in MPS is complex and often inadequate, healthcare providers work with various approaches: paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), and in severe cases stronger painkillers. Physical therapy, occupational therapy and home environmental modifications can also help. However, there is still little research into optimal pain management strategies specifically for MPS.

Gene therapy

ExperimentaliOngoing in study setting, outcome still unknown

Gene therapy aims to repair or replace the faulty gene that causes MPS. Several clinical trials are underway or in preparation, for example for MPS I and MPS II. The approach is promising but still in early stages. It may take years before definitive results are available and a treatment is officially approved. Participation in a clinical trial only occurs after thorough screening and informed consent.

Substrate reduction therapy (SRT)

ResearchediPositive results in clinical studies, not yet standard treatment

Substrate reduction therapy reduces the production of the substance that accumulates in cells with an MPS enzyme defect. For several MPS types, studies are underway or under evaluation. The idea is that less accumulation of toxic substances can help, possibly in combination with enzyme replacement therapy. To date, only a few SRT drugs are in development; clinical evidence is still limited.

Chaperone-assisted therapy (pharmacological chaperones)

ExperimentaliOngoing in study setting, outcome still unknown

Chaperone proteins can help the faulty enzyme fold correctly so it works better. This research area is in its infancy for MPS. There are some preclinical and early clinical studies underway, but currently there are no approved chaperone drugs specifically for MPS available.

Hematopoietic stem cell transplantation (HSCT)

ResearchediPositive results in clinical studies, not yet standard treatment

In stem cell transplantation, bone marrow is replaced with healthy cells from a donor or from the patient's own body tissue. This can help because the new cells can produce the missing enzyme. HSCT has been described in the medical literature for certain MPS types (particularly MPS I without severe neurological involvement). Success depends heavily on timing, donor matching and complications. This approach is invasive and carries risks such as infection, graft rejection and prolonged hospitalization.

Physical therapy and exercise programs

ResearchediPositive results in clinical studies, not yet standard treatment

Regular movement and targeted exercises can maintain joint mobility, strengthen muscles and reduce pain. Physical therapists develop tailored programmes, taking into account the limited mobility and fatigue that MPS patients may experience. This is not a medication, but a supportive measure. Studies show that consistent guidance can have benefits for mobility and quality of life.

Orthopedic interventions

ResearchediPositive results in clinical studies, not yet standard treatment

Because MPS often causes skeletal deformities and joint changes, orthopedic surgery may be necessary: for example, correction of the spine, prostheses or arthroscopic procedures. These interventions reduce pain and improve mobility. They are supportive and not curative; they are weighed per patient and based on symptoms.

Dietary modifications and nutritional supplements

UnproveniNo scientific evidence that it works

Some parents and patients try diets or nutritional supplements (for example, supplements with glucosamine, omega-3 or specific amino acids) in the hope that this slows MPS progression. However, scientific evidence for efficacy is lacking. It is unlikely that nutrition corrects the underlying enzyme defect. However, adequate nutrition is important for overall health.

Acupuncture

UnproveniNo scientific evidence that it works

Acupuncture is sometimes used for pain relief in many conditions, including serious chronic diseases. For MPS specifically, research is lacking. No biological mechanism has been demonstrated by which acupuncture could address the underlying problem of MPS.

Homeopathy

Advised againstiProven ineffective or harmful, or dangerous in combination with your treatment

Homeopathic remedies contain no active substances in measurable quantities and have no demonstrated efficacy in hereditary metabolic diseases such as MPS. Their use can prevent patients from following proven treatments. For a disease like MPS, where slowing progression is possible with recognized medications, switching to unproven remedies is unjustifiable.

Hyperbaric oxygen therapy

Advised againstiProven ineffective or harmful, or dangerous in combination with your treatment

Although hyperbaric oxygen is sometimes offered for various conditions, there is no scientific evidence that it has an effect on MPS. Moreover, it can carry risks, and if it delays or replaces regular treatment, this can be harmful.

Herbal remedies and traditional medicines

UnproveniNo scientific evidence that it works

Various herbal remedies are promoted as "supportive" for hereditary diseases. For MPS, research is completely lacking. Moreover, some herbs can cause interactions with recognized medications (including enzyme replacement therapy) or have side effects. Consult your healthcare provider before adding herbs.

Psychological support and coping strategies

ResearchediPositive results in clinical studies, not yet standard treatment

MPS is a serious, progressive disease with major impact on daily life and future. Psychological guidance can help with processing diagnosis, depression, anxiety and adjustment. This is not an "alternative treatment" of the MPS itself, but an important part of comprehensive care. Studies show that good mental health influences quality of life and treatment adherence.

---

_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._

↑ Back to top

Sources used

Above each source is one sentence about what the research concerns, so you don't have to rely on an English technical title. More studies on Mucopolysaccharidosis can be found at publications and studies.

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.